ETF Holdings Breakdown of GRFS

Stock Name	Grifols SA ADR
Ticker	GRFS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US3984384087
LEI	959800HSSNXWRKBK4N60

GRFS institutional holdings

The adjusted close for GRFS on 2025-11-11 was 8.73

The following institutional investment holdings of GRFS have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-11 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 78,376 USD 684,222 8.73

2025-11-11 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 78,376 USD 684,222 1.5% 8.73

Total = 156,752 USD 1,368,444
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	78,376	USD 684,222	8.73
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	78,376	USD 684,222 1.5%	8.73
Total =	156,752	USD 1,368,444

News associated with GRFS

Analysts Set Grifols, S.A. (NASDAQ:GRFS) Price Target at $10.30: Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-09-12 02:01:00
Ballentine Partners LLC Purchases Shares of 10,868 Grifols, S.A. (NASDAQ:GRFS): Ballentine Partners LLC acquired a new stake in Grifols, S.A. (NASDAQ:GRFS – Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,868 shares of the biotechnology company’s stock, valued at approximately $77,000. Several other institutional investors and hedge funds also recently […] - 2025-07-18 05:11:00
Wall Street Zen Upgrades Grifols (NASDAQ:GRFS) to “Strong-Buy”: Grifols (NASDAQ:GRFS – Get Free Report) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Monday. Separately, JPMorgan Chase & Co. lifted their target price on shares of Grifols from $7.60 to $10.30 and gave the company a “neutral” rating in a report on Tuesday, […] - 2025-07-09 02:10:51
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Grifols (NASDAQ:GRFS) Stock: Grifols (NASDAQ:GRFS – Get Free Report) had its target price lifted by equities researchers at JPMorgan Chase & Co. from $7.60 to $10.30 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 18.39% […] - 2025-06-19 02:42:47
Vident Advisory LLC Boosts Stock Holdings in Grifols, S.A. (NASDAQ:GRFS): Vident Advisory LLC raised its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 55.5% during the fourth quarter, HoldingsChannel reports. The firm owned 29,662 shares of the biotechnology company’s stock after purchasing an additional 10,590 shares during the period. Vident Advisory LLC’s holdings in Grifols were worth $221,000 as of its most […] - 2025-05-30 05:44:55
12,251 Shares in Grifols, S.A. (NASDAQ:GRFS) Acquired by Raymond James Financial Inc.: Raymond James Financial Inc. acquired a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 12,251 shares of the biotechnology company’s stock, valued at approximately $91,000. Several other institutional investors and hedge funds […] - 2025-05-14 04:22:48
First Trust Advisors LP Invests $75,000 in Grifols, S.A. (NASDAQ:GRFS): First Trust Advisors LP purchased a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,048 shares of the biotechnology company’s stock, valued at approximately $75,000. Other institutional investors also recently added to or […] - 2025-05-12 04:44:55
Grifols, S.A. (NASDAQ:GRFS) Shares Purchased by Mariner LLC: Mariner LLC increased its position in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 382.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 119,472 shares of the biotechnology company’s stock after purchasing an additional 94,706 shares during the period. Mariner […] - 2025-04-29 05:22:53
Legal & General Group Plc Raises Holdings in Grifols, S.A. (NASDAQ:GRFS): Legal & General Group Plc lifted its stake in Grifols, S.A. (NASDAQ:GRFS – Free Report) by 159.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 329,953 shares of the biotechnology company’s stock after purchasing an additional 202,796 shares during the quarter. Legal & General […] - 2025-04-25 05:16:54
Bank of Montreal Can Sells 6,039 Shares of Grifols, S.A. (NASDAQ:GRFS): Bank of Montreal Can cut its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 7.9% during the fourth quarter, Holdings Channel reports. The fund owned 70,856 shares of the biotechnology company’s stock after selling 6,039 shares during the quarter. Bank of Montreal Can’s holdings in Grifols were worth $527,000 as of its […] - 2025-04-22 04:52:58
Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Arrowstreet Capital Limited Partnership: Arrowstreet Capital Limited Partnership cut its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 18.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 363,933 shares of the biotechnology company’s stock after selling 84,503 shares during the quarter. Arrowstreet […] - 2025-04-10 05:15:10
Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Oppenheimer Asset Management Inc.: Oppenheimer Asset Management Inc. lowered its holdings in Grifols, S.A. (NASDAQ:GRFS – Free Report) by 38.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 36,083 shares of the biotechnology company’s stock after selling 22,594 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in […] - 2025-03-07 06:45:05
R Squared Ltd Makes New $28,000 Investment in Grifols, S.A. (NASDAQ:GRFS): R Squared Ltd purchased a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,760 shares of the biotechnology company’s stock, valued at approximately $28,000. Several other institutional investors and hedge […] - 2025-02-05 06:40:56
China Universal Asset Management Co. Ltd. Raises Stock Position in Grifols, S.A. (NASDAQ:GRFS): China Universal Asset Management Co. Ltd. raised its stake in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 10.2% during the fourth quarter, Holdings Channel reports. The firm owned 25,867 shares of the biotechnology company’s stock after buying an additional 2,403 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Grifols […] - 2025-02-04 07:14:57

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.